Murat İlhan Atagün1, Elif Muazzez Şıkoğlu2, Serdar Süleyman Can3, Görkem Karakaş Uğurlu3, Semra Ulusoy Kaymak4, Ali Çayköylü3, Oktay Algın5, Mary L Phillips6, Constance M Moore2, Dost Öngür7. 1. Department of Psychiatry, Ankara Yıldırım Beyazıt University Medical School, Ankara, Turkey; Department of Psychiatry, Ankara Atatürk Training and Education Hospital, Ankara, Turkey. Electronic address: miatagun@ybu.edu.tr. 2. Center for Comparative NeuroImaging, Department of Psychiatry and Radiology, University of Massachusetts Medical School, Worcester, MA, USA. 3. Department of Psychiatry, Ankara Yıldırım Beyazıt University Medical School, Ankara, Turkey; Department of Psychiatry, Ankara Atatürk Training and Education Hospital, Ankara, Turkey. 4. Department of Psychiatry, Ankara Atatürk Training and Education Hospital, Ankara, Turkey. 5. Department of Radiology, Ankara Atatürk Training and Education Hospital, Ankara, Turkey; National MR Research Center and Aysel Sabuncu Brain Research Center, Bilkent University, Ankara, Turkey. 6. Department of Psychiatry, University of Pittsburgh, Medical School, Pittsburgh, PA, USA. 7. Psychotic Disorders Division, McLean Hospital (Belmont), MA, USA; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND: Despite the diagnostic challenges in categorizing bipolar disorder subtypes, bipolar I and II disorders (BD-I and BD-II respectively) are valid indices for researchers. Subtle neurobiological differences may underlie clinical differences between mood disorder subtypes. The aims of this study were to investigate neurochemical differences between bipolar disorder subtypes. METHODS: Euthymic BD-II patients (n = 21) are compared with BD-I (n = 28) and healthy comparison subjects (HCs, n = 30). Magnetic Resonance Imaging (MRI) and proton spectroscopy (1H MRS) were performed on a 3T Siemens Tim Trio system. MRS voxels were located in the left/right superior temporal cortices, and spectra acquired with the single voxel Point REsolved Spectroscopy Sequence (PRESS). The spectroscopic data were analyzed with LCModel (Version 6.3.0) software. RESULTS: There were significant differences between groups in terms of glutamate [F = 6.27, p = 0.003], glutamate + glutamine [F = 6.08, p = 0.004], inositol containing compounds (Ino) (F = 9.25, p < 0.001), NAA [F = 7.63, p = 0.001] and creatine + phosphocreatine [F = 11.06, p < 0.001] in the left hemisphere and Ino [F = 5.65, p = 0.005] in the right hemisphere. Post-hoc comparisons showed that the BD-I disorder group had significantly lower metabolite levels in comparison to the BD-II and the HC groups. LIMITATIONS: This was a cross-sectional study with a small sample size. In addition, patients were on various psychotropic medications, which may have impacted the results. CONCLUSIONS: Neurochemical levels, in the superior temporal cortices, measured with 1H-MRS discriminated between BD-II and BD-I. Although further studies are needed, one may speculate that the superior temporal cortices (particularly left hemispheric) play a critical role, whose pathology may be related to subtyping bipolar disorder.
BACKGROUND: Despite the diagnostic challenges in categorizing bipolar disorder subtypes, bipolar I and II disorders (BD-I and BD-II respectively) are valid indices for researchers. Subtle neurobiological differences may underlie clinical differences between mood disorder subtypes. The aims of this study were to investigate neurochemical differences between bipolar disorder subtypes. METHODS: Euthymic BD-II patients (n = 21) are compared with BD-I (n = 28) and healthy comparison subjects (HCs, n = 30). Magnetic Resonance Imaging (MRI) and proton spectroscopy (1H MRS) were performed on a 3T Siemens Tim Trio system. MRS voxels were located in the left/right superior temporal cortices, and spectra acquired with the single voxel Point REsolved Spectroscopy Sequence (PRESS). The spectroscopic data were analyzed with LCModel (Version 6.3.0) software. RESULTS: There were significant differences between groups in terms of glutamate [F = 6.27, p = 0.003], glutamate + glutamine [F = 6.08, p = 0.004], inositol containing compounds (Ino) (F = 9.25, p < 0.001), NAA [F = 7.63, p = 0.001] and creatine + phosphocreatine [F = 11.06, p < 0.001] in the left hemisphere and Ino [F = 5.65, p = 0.005] in the right hemisphere. Post-hoc comparisons showed that the BD-I disorder group had significantly lower metabolite levels in comparison to the BD-II and the HC groups. LIMITATIONS: This was a cross-sectional study with a small sample size. In addition, patients were on various psychotropic medications, which may have impacted the results. CONCLUSIONS: Neurochemical levels, in the superior temporal cortices, measured with 1H-MRS discriminated between BD-II and BD-I. Although further studies are needed, one may speculate that the superior temporal cortices (particularly left hemispheric) play a critical role, whose pathology may be related to subtyping bipolar disorder.
Authors: Murat İlhan Atagün; Elif Muazzez Şıkoğlu; Çağlar Soykan; Can Serdar Süleyman; Semra Ulusoy-Kaymak; Ali Çayköylü; Oktay Algın; Mary Louise Phillips; Dost Öngür; Constance Mary Moore Journal: Neurosci Lett Date: 2016-11-24 Impact factor: 3.046
Authors: Brent M McGrath; Phillip H Wessels; Emily C Bell; Michele Ulrich; Peter H Silverstone Journal: Can J Psychiatry Date: 2004-12 Impact factor: 4.356
Authors: Elisa Ambrosi; Maria Camilla Rossi-Espagnet; Georgios D Kotzalidis; Anna Comparelli; Antonio Del Casale; Filippo Carducci; Andrea Romano; Giovanni Manfredi; Roberto Tatarelli; Alessandro Bozzao; Paolo Girardi Journal: J Affect Disord Date: 2013-03-11 Impact factor: 4.839
Authors: Jonathan Chabert; Etienne Allauze; Bruno Pereira; Carine Chassain; Ingrid De Chazeron; Jean-Yves Rotgé; Philippe Fossati; Pierre-Michel Llorca; Ludovic Samalin Journal: Int J Mol Sci Date: 2022-08-11 Impact factor: 6.208
Authors: Thomas Drago; Patrick W O'Regan; Ivan Welaratne; Shane Rooney; Aoife O'Callaghan; Marissa Malkit; Elena Roman; Kirk J Levins; Lauren Alexander; Denis Barry; Erik O'Hanlon; Veronica O'Keane; Darren William Roddy Journal: Syst Rev Date: 2018-10-12
Authors: Kirk J Levins; Thomas Drago; Elena Roman; Anna Martin; Roisin King; Paul Murphy; Hugh Gallagher; Denis Barry; Erik O'Hanlon; Darren William Roddy Journal: Syst Rev Date: 2019-12-27